期刊文献+

网膜素与肥胖及胰岛素抵抗的关系 被引量:1

Relationship between omentin and obesity, insulin resistance
原文传递
导出
摘要 网膜素是新近发现的一种脂肪细胞因子,特异性表达于内脏脂肪组织。目前研究表明,网膜素能促进皮下和网膜脂肪细胞胰岛素刺激的葡萄糖转运和蛋白激酶B磷酸化,且与肥胖相关,在调节糖代谢中具有一定作用。因此,对网膜素的表达、作用机制及生物学功能的深入研究,有助于进一步阐明肥胖、代谢综合征及糖尿病等的发病机制.从而为这砦疾病的治疗提供新的方向。 Omentin is a novel visceral fat depot-specific adipokine. Current studies have shown that omcntin enhances insulin-stimulated glucose transport and Akt phosphorylation in human subcutaneous as well as visceral adipocytes. It's also related to obesity,and play a certain role in the regulation of glucose metabolism. Further study of omentin's expression, mechanism and biological functions is benefit for clarifying the pathogenesis of obesity,metabolic syndrome and diabetes, and may provide a new therapeutic direction for these diseases.
出处 《国际内分泌代谢杂志》 2010年第B04期31-33,共3页 International Journal of Endocrinology and Metabolism
基金 甘肃省科学技术攻关计划项目(0708NKCA099)
关键词 网膜素 肥胖 胰岛素抵抗 代谢综合征 Omentin Obesity Diabetes mcllitus Metabolic syndrome
  • 相关文献

参考文献14

  • 1宁光,杨军,杨义生,张翼飞,顾卫琼,洪洁,李小英,陈名道,许曼音,陈家伦.脂肪细胞因子的临床和基础研究[J].国外医学(内分泌学分册),2005,25(3):158-160. 被引量:40
  • 2Yang RZ.Xu A,Pray J,et al.Cloning of omentin,a new adipocytokine from omental fat tissue in human.Diabetes,2005,52:A1.
  • 3Yang RZ,Lee MJ,Hu H,et al.Identification of omentin as a novel depot-specific adipokine in human adipose tissue:Possible role in modulating insulin action.Am J Physiol,2006,290:E1253-E1261.
  • 4Schaffler A,Neumeier M,Herfarth H,et al.Genomic structure of human omentin,a new adipocytokine expressed in omental adipose tissue.Biochim Biophys Acta,2005,1732:96-102.
  • 5de Souza Batista CM,Yang RZ,Lee MJ,et al.Omentin plasma levels and gene expression are decreased in obesity.Diabetes,2007,56:1655-1661.
  • 6Tan BK,Adya R,Farhatullah S,et al.Omentin-1,a novel adipokine,is decreased in overweight insulin-resistant women with polyeystic ovary syndrome:Ex vivo and in vivo regulation of omentin-1 by insulin and glucose.Diabetes,2008,57:801-808.
  • 7Matsuzawa Y.The metabolic syndrome and adipecytokines.FEBS Lett,2006,580:2917 -2921.
  • 8Kralisch S,Klein J,Bluher M,et al.Therapeutic perspectives of adipocytokines.Expert Opin Pharmacother,2005,6:863-872.
  • 9Bajala MW,Obici S,scherer PE,et al.Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.J Clin Invest,2003,111:225-230.
  • 10Okamoto Y,Kihara S,Funahashi T,et al.Adiponectin:A key adipocytokine in metabolic syndrome.Clin Sci (Lond),2006,110:267-278.

二级参考文献12

  • 1陈宇红,毕宇芳,张连珍,胡仁明,赵咏桔,宁光.肥胖者与糖尿病患者胰岛素敏感性的变化[J].中华内分泌代谢杂志,2004,20(3):213-214. 被引量:12
  • 2宁光,顾卫琼,徐敏,杜鹏飞,洪洁,张翼飞,李小英.脂联素:从胰岛素抵抗到胰岛β细胞功能[J].中华内分泌代谢杂志,2004,20(4). 被引量:12
  • 3顾卫琼,陈名道,顾元骏,唐金凤,孙首悦,刘长勤,洪洁,张翼飞,李小英,宁光.脂联素受体在胰岛细胞表达,脂联素促进胰岛素的分泌[J].中华内分泌代谢杂志,2005,21(1):68-70. 被引量:34
  • 4Laza MA. How obesity causes diabetes: not a tall tale. Science,2005,307: 373-375.
  • 5Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005,307:426-430.
  • 6Gu WQ, Hong J, Zhang YF, et al. Study on obesity related factors:FFA, Leptin and adiponectin in subjects with varying glucose tolerance.Journal of Shanghai Second Medical University (English), 2005, 17: 18-22.
  • 7YangYS, SongHD, LiRY, etal. The gene expression profiling of human visceral adipose tissue and its secretory functions. Biochem Biophys Res Commun, 2003,300: 839-846.
  • 8Schwartz MW,Porte D Jr. Diabetes, obesity, and the brain. Science,2005,307: 375-379.
  • 9Qi Y, Takahashi N, Hileman SM, et al. Adiponectin acts in the brain to decrease body weight. Nat Med,2004,10:524-529.
  • 10洪洁,宁光,王笑微,王曙,顾卫琼,胡仁明,罗邦尧,许曼音,陈家伦.减少样本数的Bergman最小模型技术在胰岛素抵抗综合征中的应用[J].中华内分泌代谢杂志,2000,16(6):358-362. 被引量:45

共引文献39

同被引文献24

  • 1李宏亮,余叶蓉,喻红玲,王椿,张祥迅.单纯性肥胖患者外周胰岛素抵抗与﹀细胞功能的研究[J].四川大学学报(医学版),2005,36(3):378-381. 被引量:9
  • 2梁真,程桦,李焱,黎锋,黄秀琼,聂佩珍,戚以勤.应用高葡萄糖钳夹技术评价高甘油三酯血症人群胰岛素分泌和胰岛素敏感性[J].中华内分泌代谢杂志,2005,21(3):211-214. 被引量:21
  • 3刘军,查英,盛励,陈灶萍,陈钦达,廖晓寰,吴强,孟令平.腹型肥胖患者胰岛β细胞功能和胰岛素敏感性的变化[J].复旦学报(医学版),2006,33(3):393-396. 被引量:24
  • 4李桂源主编.病理生理学[M].2版.北京:人民卫生出版社,2010:34-38.
  • 5Lee S, Chun K, Lee S, Kim D. Does Abdominal Obesity Accelerate the Effect of Hypertriglyceridemia on Impaired Fasting Glucose [J]. Yonsei Med J,2010,51 (3) :360-366.
  • 6Hagman DK, Hays LB, Parazzoli SD, et al. Palmitate inhibits insu- lin gene expression by altering PDX-1 nuclear localization and re- ducing MafA expression in isolated rat islets of Langerhans [ J ]. J Biol Chem,2005,280(37) :32413-32418.
  • 7Fontbs G, Meriem Semache M, Hagman DK, et al. Involvement of per-arnt-sim kinase and extracellular-regulated kinases-1/2 in pal- mitate inhibition of insulin gene expression in panereatJ3-ceUs E g ]. Diabetes,2009,58 ( 9 ) : 2048 -2058.
  • 8Zhang Y, Xiao M, Niu G,et aL Mechanisms of oleic acid deteriora- tion in insulin secretion : role in the pathogenesis of type 2 diabetes EJ]. Lift Sci,2005,77(17) :2071-2081.
  • 9Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance E J 1. Physiol Rev,2007, 87 (2) :507-520.
  • 10Kato T,Shiumno H,Yamamoto T,et a/. Palmitate impairs and ei-eosa- pentaenoate restores insulin secretion through regulation of SREBP-1 c in pancreatic islets[J]. Diabetes,2008,57(9) :2382-2392.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部